GMRE-PA:NYE-Global Medical REIT Inc (USD)

PREFERRED SHARE | REIT—Healthcare Facilities | NYE

Last Closing Price

USD 26.17

Change

0.00 (0.00)%

Market Cap

USD 0.42B

Volume

1.25K

Average Target Price

N/A
Average Analyst Rating

N/A

Fundamental Analysis

Verdict

About

Global Medical REIT Inc. is net-lease medical office REIT that acquires purpose-built specialized healthcare facilities and leases those facilities to strong healthcare systems and physician groups with leading market share.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2020-09-26 )

Largest Industry Peers for REIT—Healthcare Facilities

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
WELL Welltower Inc

N/A

USD22.23B 15.44 21.32
VTR Ventas, Inc

N/A

USD15.55B 36.96 13.63
MPW Medical Properties Trust, Inc

N/A

USD9.06B 19.58 17.33
OHI Omega Healthcare Investors, In..

N/A

USD6.79B 17.34 12.89
HTA Healthcare Trust of America, I..

N/A

USD5.58B 181.21 19.54
HR Healthcare Realty Trust Incorp..

N/A

USD3.96B 35.12 15.59
DOC Physicians Realty Trust

N/A

USD3.62B 37.17 16.21
NHI National Health Investors, Inc

N/A

USD2.65B 15.36 13.63
GEO The GEO Group, Inc

N/A

USD1.33B 8.70 9.57
LTC LTC Properties, Inc

N/A

USD1.32B 12.65 19.20

ETFs Containing GMRE-PA

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (REIT—Healthcare Facilities)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -2.91% 86% B 63% D
Dividend Return 1.74% 7% F 53% F
Total Return -1.17% 86% B 63% D
Trailing 12 Months  
Capital Gain -2.19% 79% C+ 58% F
Dividend Return 3.50% 21% F 68% D+
Total Return 1.32% 79% C+ 61% D-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -0.33% N/A N/A 40% F
Dividend Return 0.65% N/A N/A 21% F
Total Return 0.32% N/A N/A 32% F
Risk Return Profile  
Volatility (Standard Deviation) 0.77% N/A N/A 99% A+
Risk Adjusted Return 41.75% N/A N/A 58% F
Market Capitalization 0.42B 7% F 44% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.